Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 7
2006 7
2007 5
2008 5
2009 8
2010 6
2011 8
2012 10
2013 7
2014 6
2015 9
2016 14
2017 12
2018 15
2019 6
2020 17
2021 28
2022 17
2023 23
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Results by year

Filters applied: . Clear all
Page 1
An NK-like CAR T cell transition in CAR T cell dysfunction.
Good CR, Aznar MA, Kuramitsu S, Samareh P, Agarwal S, Donahue G, Ishiyama K, Wellhausen N, Rennels AK, Ma Y, Tian L, Guedan S, Alexander KA, Zhang Z, Rommel PC, Singh N, Glastad KM, Richardson MW, Watanabe K, Tanyi JL, O'Hara MH, Ruella M, Lacey SF, Moon EK, Schuster SJ, Albelda SM, Lanier LL, Young RM, Berger SL, June CH. Good CR, et al. Among authors: watanabe k. Cell. 2021 Dec 9;184(25):6081-6100.e26. doi: 10.1016/j.cell.2021.11.016. Epub 2021 Dec 2. Cell. 2021. PMID: 34861191 Free PMC article.
Driving cars to the clinic for solid tumors.
Castellarin M, Watanabe K, June CH, Kloss CC, Posey AD Jr. Castellarin M, et al. Among authors: watanabe k. Gene Ther. 2018 Jun;25(3):165-175. doi: 10.1038/s41434-018-0007-x. Epub 2018 Jun 7. Gene Ther. 2018. PMID: 29880908 Review.
Elderly sarcoidosis in Japan.
Masumoto N, Watanabe K, Horita N, Hara Y, Kobayashi N, Kaneko T. Masumoto N, et al. Among authors: watanabe k. J Int Med Res. 2022 Dec;50(12):3000605221142705. doi: 10.1177/03000605221142705. J Int Med Res. 2022. PMID: 36562117 Free PMC article.
Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial).
Okuma HS, Watanabe K, Tsuchihashi K, Machida R, Sadachi R, Hirakawa A, Ariyama H, Kanai M, Kamikura M, Anjo K, Hiramitsu A, Sekine S, Okita N, Mano H, Nishikawa H, Nakamura K, Yonemori K. Okuma HS, et al. Among authors: watanabe k. Clin Cancer Res. 2023 Dec 15;29(24):5079-5086. doi: 10.1158/1078-0432.CCR-23-1807. Clin Cancer Res. 2023. PMID: 37819940 Free PMC article. Clinical Trial.
Adverse events induced by durvalumab and tremelimumab combination regimens: a systematic review and meta-analysis.
Matsumoto H, Somekawa K, Horita N, Ueda S, Kaneko M, Kaneko A, Fukuda N, Izawa A, Kamimaki C, Tanaka K, Murohashi K, Fuji H, Tagami Y, Aoki A, Watanabe K, Hara Y, Kobayashi N, Kaneko T. Matsumoto H, et al. Among authors: watanabe k. Ther Adv Med Oncol. 2023 Sep 13;15:17588359231198453. doi: 10.1177/17588359231198453. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37720498 Free PMC article. Review.
The cancer epigenome: Non-cell autonomous player in tumor immunity.
Kato S, Maeda Y, Sugiyama D, Watanabe K, Nishikawa H, Hinohara K. Kato S, et al. Among authors: watanabe k. Cancer Sci. 2023 Mar;114(3):730-740. doi: 10.1111/cas.15681. Epub 2022 Dec 18. Cancer Sci. 2023. PMID: 36468774 Free PMC article. Review.
The clinical impact of comorbidities among patients with idiopathic pulmonary fibrosis undergoing anti-fibrotic treatment: A multicenter retrospective observational study.
Aoki A, Hara Y, Fujii H, Murohashi K, Nagasawa R, Tagami Y, Enomoto T, Matsumoto Y, Masuda M, Watanabe K, Horita N, Kobayashi N, Kudo M, Ogura T, Kaneko T. Aoki A, et al. Among authors: watanabe k. PLoS One. 2023 Sep 19;18(9):e0291489. doi: 10.1371/journal.pone.0291489. eCollection 2023. PLoS One. 2023. PMID: 37725604 Free PMC article.
191 results